These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 24261406)

  • 1. Aluminum elution and precipitation in glass vials: effect of pH and buffer species.
    Ogawa T; Miyajima M; Wakiyama N; Terada K
    Drug Dev Ind Pharm; 2015 Feb; 41(2):315-21. PubMed ID: 24261406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of phosphate buffer in parenteral drugs on particle formation from glass vials.
    Ogawa T; Miyajima M; Wakiyama N; Terada K
    Chem Pharm Bull (Tokyo); 2013; 61(5):539-45. PubMed ID: 23420583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparisons of Aluminum and Silica Elution from Various Glass Vials.
    Ogawa T; Miyajima M; Nishimoto N; Minami H; Terada K
    Chem Pharm Bull (Tokyo); 2016; 64(2):150-60. PubMed ID: 26656229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complexing Agents and pH Influence on Chemical Durability of Type I Molded Glass Containers.
    Biavati A; Poncini M; Ferrarini A; Favaro N; Scarpa M; Vallotto M
    PDA J Pharm Sci Technol; 2017; 71(4):306-316. PubMed ID: 28747538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative Leachable Study of Glass Vials to Demonstrate the Impact of Low Fill Volume.
    Hladik B; Buscke F; Frost R; Rothhaar U
    PDA J Pharm Sci Technol; 2019; 73(4):345-355. PubMed ID: 30770482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Contribution to an Understanding of Complexing Agents and Salt Solutions Reaction Mechanism on Chemical Attack of Type I Molded Glass Containers.
    Biavati A; Severi G; Bisceglie F; Marchegiani M; Ferrarini A
    PDA J Pharm Sci Technol; 2019; 73(6):538-551. PubMed ID: 31101704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. There Is Still Room for Improvement: Presentation of a Neutral Borosilicate Glass with Improved Chemical Stability for Parenteral Packaging.
    Boltres B; Tratzky S; Kass C; Eichholz R; Naß P
    PDA J Pharm Sci Technol; 2016; 70(4):346-52. PubMed ID: 27091891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aluminum in erythropoietin formulations: lyophilized versus liquid forms.
    Veiga M; Bohrer D; Noremberg S; Mattiazzi P; do Nascimento PC; de Carvalho LM
    Ren Fail; 2013; 35(3):391-5. PubMed ID: 23343454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accelerated extractable studies of borosilicate glass containers.
    Borchert SJ; Ryan MM; Davison RL; Speed W
    J Parenter Sci Technol; 1989; 43(2):67-79. PubMed ID: 2709238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IgG1 adsorption to siliconized glass vials-influence of pH, ionic strength, and nonionic surfactants.
    Höger K; Mathes J; Frieß W
    J Pharm Sci; 2015 Jan; 104(1):34-43. PubMed ID: 25394280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delamination propensity of pharmaceutical glass containers by accelerated testing with different extraction media.
    Guadagnino E; Zuccato D
    PDA J Pharm Sci Technol; 2012; 66(2):116-25. PubMed ID: 22492597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of citric acid on aluminum hydrolytic speciation.
    Kuan WH; Wang MK; Huang PM; Wu CW; Chang CM; Wang SL
    Water Res; 2005 Sep; 39(15):3457-66. PubMed ID: 16112170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silicate release from glass for pharmaceutical preparations.
    Bohrer D; Bortoluzzi F; Nascimento PC; Carvalho LM; Ramirez AG
    Int J Pharm; 2008 May; 355(1-2):174-83. PubMed ID: 18272302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ESCA depth profiling studies of borosilicate glass containers.
    Borchert SJ; Maxwell RJ
    J Parenter Sci Technol; 1990; 44(3):153-82. PubMed ID: 2370625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stability of Octastatin, a somatostatin analog cyclic octapeptide, in aqueous solution.
    Jang SW; Woo BH; Lee JT; Moon SC; Lee KC; DeLuca PP
    Pharm Dev Technol; 1997 Nov; 2(4):409-14. PubMed ID: 9552470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delamination Propensity of Glass Containers for Pharmaceutical Use: A Round Robin Activity Looking for a Predictive Test.
    Cerdan-Diaz J; Choju K; Flynn CR; Gavioli L; Iacocca R; Meysner A; Pfeifer J; Roehl H; Rupertus V; Scarpa M; Sun H; Zhang J; Zuccato D; Guglielmi M
    PDA J Pharm Sci Technol; 2018; 72(6):553-565. PubMed ID: 29954923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mapping of solution components, pH changes, protein stability and the elimination of protein precipitation during freeze-thawing of fibroblast growth factor 20.
    Maity H; Karkaria C; Davagnino J
    Int J Pharm; 2009 Aug; 378(1-2):122-35. PubMed ID: 19505546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of B2O3 on the removal of phosphate ions from an aqueous solution in borosilicate glasses.
    Nam JS; Kim CY
    J Hazard Mater; 2009 Dec; 172(2-3):1013-20. PubMed ID: 19699580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stabilization of minodronic acid in aqueous solution for parenteral formulation.
    Nakamura K; Tanaka T; Saito K; Yokohama S; Sonobe T
    Int J Pharm; 2001 Jul; 222(1):91-9. PubMed ID: 11404035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physicochemical stability of pharmaceutical phosphate buffer solutions II. Complexation behavior of Al(III) with additives in phosphate buffer solutions.
    Hasegawa K; Hashi K; Okada R
    J Parenter Sci Technol; 1982; 36(4):168-73. PubMed ID: 6813447
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.